7 results
8-K
BDTX
Black Diamond Therapeutics Inc
12 Dec 22
Black Diamond Therapeutics Announces Spinout of Launchpad Therapeutics, Inc., an Antibody-Focused Precision Oncology Company
8:04am
of the antibody programs and the license, the Company received 9.0 million shares of common stock in Launchpad, representing a minority stake. The Company’s
8-K
EX-99.1
BDTX
Black Diamond Therapeutics Inc
12 Dec 22
Black Diamond Therapeutics Announces Spinout of Launchpad Therapeutics, Inc., an Antibody-Focused Precision Oncology Company
8:04am
to discover, develop and commercialize large molecule therapeutics. In exchange, Black Diamond received a minority ownership stake in Launchpad
PRE 14A
6ad0 2ydr
12 Apr 24
Preliminary proxy
4:48pm
DEF 14A
ya8i5rajjb1oz
27 Apr 21
Definitive proxy
4:06pm
- Prev
- 1
- Next